A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Brisbane and Women'S Hospital
Herston, Brisbane, Australia
- Bankstown-Lidcombe Hospital
Bankstown, New South Wales, Australia
- Monash Health
Melbourne, Victoria, Australia
- St Vincent'S Hospital Sydney
Darlinghurst, Australia
- Linear Clinical Research
Nedlands, Australia
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Sunnybrook Health Sciences Centre - Bayview Campus
Toronto, Ontario, Canada
- Prince of Wales Hospital
Shatin, New Territories, Hong Kong
- Queen Mary Hospital
Hong Kong, Pok Fu Lam, Hong Kong
- Humanity & Health Clinical Trial Centre
Hong Kong, Hong Kong
- Curie Oncology
Singapore, Singapore
- National Cancer Centre Singapore
Singapore, Singapore
- Tan Tock Seng Hospital
Singapore, Singapore
- China Medical University Hospital
Taichung, Taichung City, Taiwan
- National Cheng Kung University Hospital
Tainan, Tainan City, Taiwan
- National Taiwan University Hospital
Tainan, Taipei City, Taiwan
- Taipei Veterans General Hospital
Taipei, Taipei City, Taiwan
- Chi Mei Medical Center
Tainan, Taiwan
- Linkou Chang Gung Memorial Hospital (cgmhlk)
Taoyuan City, Taiwan
- Mayo Clinic - Scottsdale
Scottsdale, Arizona, United States
- University of Arizona - Cancer Center
Tucson, Arizona, United States
- Beverly Hills Cancer Center
Beverly Hills, California, United States
- City of Hope
Duarte, California, United States
- City of Hope at Irvine Lennar
Irvine, California, United States
- Cancer & Blood Specialty Clinic
Lakewood, California, United States
- Usc Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Sarcoma Oncology Center
Santa Monica, California, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- the Winship Cancer Institute Emory University
Atlanta, Georgia, United States
- Mountain States Tumor Institute at St. Luke'S Regional Medical Center
Boise, Idaho, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- Uofl Health Brown Cancer Center
Louisville, Kentucky, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Christus St. Vincent Regional Medical Center
Santa Fe, New Mexico, United States
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- University of North Carolina (unc) - Chapel Hill
Chapel Hill, North Carolina, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (osuccc - James)
Columbus, Ohio, United States
- University of Pittsburgh Medical Center (upmc) - Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Dec 2024
- Primary completion
- 30 Sept 2027
- Completion
- 30 Sept 2027
- Last update posted
- 13 Apr 2026
- Registered enrollment
- 72
- Registry id
- NCT06679985
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.